Consistent with these in vivo findings, AITC treatment (20 μM/24 h) also significantly decreased TNF and IL-6 mRNA levels in palmitate-acid-treated AML-12 cells [44]. The gene discussed is TNF; the disease is acute myeloid leukemia.